These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension. Dzau VJ; Gibbons GH Am J Cardiol; 1987 Dec; 60(17):99I-103I. PubMed ID: 2891292 [TBL] [Abstract][Full Text] [Related]
6. New perspectives in hypertension research. Potentials of vascular biology. Dzau VJ; Gibbons GH; Morishita R; Pratt RE Hypertension; 1994 Jun; 23(6 Pt 2):1132-40. PubMed ID: 8206603 [TBL] [Abstract][Full Text] [Related]
7. Cell biology of vascular hypertrophy in systemic hypertension. Dzau VJ; Gibbons GH Am J Cardiol; 1988 Oct; 62(11):30G-35G. PubMed ID: 3051993 [TBL] [Abstract][Full Text] [Related]
8. Vascular remodeling and antihypertensive therapy: the example of cicletanine. Chabrier PE; Esanu A; Braquet P J Cardiovasc Pharmacol; 1993; 21 Suppl 1():S50-3. PubMed ID: 7681131 [TBL] [Abstract][Full Text] [Related]
9. Endothelium and growth factors in vascular remodeling of hypertension. Dzau VJ; Gibbons GH Hypertension; 1991 Nov; 18(5 Suppl):III115-21. PubMed ID: 1937673 [TBL] [Abstract][Full Text] [Related]
10. Endothelial function as a determinant of vascular function and structure: a new therapeutic target. Gibbons GH Am J Cardiol; 1997 Mar; 79(5A):3-8. PubMed ID: 9127614 [TBL] [Abstract][Full Text] [Related]
12. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide. Gibbons GH Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848 [TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and hypertension. le Noble FA; Stassen FR; Hacking WJ; Struijker Boudier HA J Hypertens; 1998 Nov; 16(11):1563-72. PubMed ID: 9856355 [TBL] [Abstract][Full Text] [Related]
14. Preventive treatment of graft coronary vascular disease: the potential role of vasodilator therapy. Gibbons GH J Heart Lung Transplant; 1992; 11(3 Pt 2):S22-7. PubMed ID: 1622995 [TBL] [Abstract][Full Text] [Related]
15. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis]. Garbuzenko DV Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515 [TBL] [Abstract][Full Text] [Related]
16. Vascular stress response and endothelial vasoactive factors for vascular remodelling. Itoh H; Nakao K Diabetes Res Clin Pract; 1999 Sep; 45(2-3):83-8. PubMed ID: 10588359 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of exosome-mediated intercellular communication in vascular remodeling. Su SA; Xie Y; Fu Z; Wang Y; Wang JA; Xiang M Oncotarget; 2017 Apr; 8(15):25700-25712. PubMed ID: 28147325 [TBL] [Abstract][Full Text] [Related]